| Metric | FY 2020 | Prior Q | FY 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $308M | — | $266M | — | 15.8% |
| Op. Income | $308M | — | $266M | — | 15.8% |
| Gross Margin | 100.0% | — | 100.0% | — | 0.0pp |
| Net Margin | 90.6% | — | 89.6% | — | 1.0pp |
| EPS (Diluted) | $2.88 | — | $2.49 | — | 15.7% |
| Free Cash Flow | $270M | — | $223M | — | 21.2% |
| Item | Amount |
|---|---|
| REVENUE | $308M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $308M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $0 |
| Operating Expenses | $0 |
| Cost & Expenses | $0 |
| OPERATING INCOME | $308M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $308M |
| Income Tax Expense | $29M |
| Net Income from Continuing Ops | $279M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $279M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $279M |
| D&A | $0 |
| EBIT | $308M |
| EBITDA | $308M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| REVENUE | $308M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $308M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $0 |
| Operating Expenses | $0 |
| Cost & Expenses | $0 |
| OPERATING INCOME | $308M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $308M |
| Income Tax Expense | $29M |
| Net Income from Continuing Ops | $279M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $279M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $279M |
| D&A | $0 |
| EBIT | $308M |
| EBITDA | $308M |
| EPS | $3 |
| EPS Diluted | $3 |
| Item | Amount |
|---|---|
| Net Income | $279M |
| Depreciation & Amortization | $0 |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | -$9M |
| Change in Working Capital | $119.0K |
| OPERATING CASH FLOW | $270M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$147.0K |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$147.0K |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$271M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$270M |
| FREE CASH FLOW | $270M |
| Net Change in Cash | $0 |
| Item | Amount |
|---|---|
| Cash & Equivalents | $0 |
| Short-Term Investments | $0 |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $0 |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $1.6B |
| Tax Assets | $0 |
| Other Non-Current Assets | -$1.6B |
| TOTAL NON-CURRENT ASSETS | $0 |
| TOTAL ASSETS | $1.6B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $0 |
| TOTAL LIABILITIES | $2M |
| Common Stock | $1.7B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | -$54M |
| TOTAL STOCKHOLDERS' EQUITY | $1.6B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.6B |
| TOTAL LIABILITIES & EQUITY | $1.6B |
| Total Debt | $0 |
| Net Debt | $0 |